Discovery 2010

Tid 19 September 2010 – 21 September 2010

Plats Red Rock Casino Resort Spa, Las Vegas, USA

Teodor Aastrup, CEO , Attana AB will be presenting on: Kinetics on cells – bridging the gap between traditional biosensors and cell-based assays The development of new pharmaceutical antibodies is a long and expensive process with sharply increasing costs during clinical trials. Widespread technologies to measure molecular interactions using purified target and ligand are powerful, but often oversimplify the interaction. This is particularly true for membrane proteins which need a membrane environment to retain their biological activity. At the same time, bioassays measure the biological effects but do not give much information regarding the dynamics of interactions. This leaves a gap in the information base which can be filled by molecular interaction measurements directly on cells. Thus, an immense improvement within the field would be to measure the true drug interaction with the native target in its biological context, the cell. Studying the interaction towards the target in its native context promises better estimates of efficacy, dosing and safety, lowering the reported 50% fall-out in Phase III. The Attana Cell™ 200 is a QCM based biosensor that provides highly informative data about drug candidates in preclinical stage, thus improving selection and reducing the risk of late failures. Two typical examples where the Attana Cell 200 proved to be beneficial will be presented; 1) study of a glycoprotein to be used as a diagnostic tool for early detection of metastatic colorectal cancer, 2) characterization of modified Herceptin® designed for targeted immunotherapy in cases of breast and ovarian carcinomas. Dr. Staffan Grenklo will also be available for meetings with conference participants. Event webpage: http://www.thediscoverysummit.com/

Kategorier

  • cell
  • attana cell 200
  • attana
  • biosensor
  • Attana Cell 200 - Label free, real time kinetics on cells, exploring biology on a new level
    Licens:
    Medieanvändning
    Ladda ner
  • Attana Cell Sensor Chip
    Licens:
    Medieanvändning
    Ladda ner
  • Attana Application Note: Characterization of complex lectin-cell kinetics
    Attana Application Note: Characterization of complex lectin-cell kinetics
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Attana Application Note: Early detection of clinical failure
    Attana Application Note: Early detection of clinical failure
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Scientific publications pertaining to the Attana systems
    Scientific publications pertaining to the Attana systems
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Attana Application Note: Glycosylation profile of cancer cells
    Attana Application Note: Glycosylation profile of cancer cells
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Attana Application Note: Crude samples analysis - Screening and characterization of hybridoma supernatants
    Attana Application Note: Crude samples analysis - Screening and characterization of hybridoma supernatants
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Attana Application Note: Crude samples analysis - Direct off-rate screening in supernatants and lysates
    Attana Application Note: Crude samples analysis - Direct off-rate screening in supernatants and lysates
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner

Relaterat innehåll

  • PEGS 2010 with Attana!

    We are happy to have met so many industry people during the Protein Engineering Summit 2010 in Boston last week, and if you were there but didn't get the chance to taste our exquisite espresso you are welcome to stop by our booth during our upcoming events!

  • Fight against cancer - Attana's collaborator interviewed

    Attana's collaborator at Gothenburg University, Dr. Sture Lindegren, is interviewed about a possible new cure for ovarian cancers. Using the Attana Cell 200 instrument, Dr. Lindegren and his team are testing antibodies as carriers of radionuclide that target cancer cells directly instead of affecting the whole body as current cancer therapies do.

  • Sveriges Radio Ekot - Attana interviewed

    Sveriges Radio Ekot has interviewed Attana's Chief Financial Officer Jesper Isaksson. The story covers how the increased value of the Swedish krona against the Euro and the US dollar influences Swedish exporting and importing companies. Jesper gives a brief input on Attana's approach.

  • Biotech companies - Ways to work more efficiently

    Ernst & Young recently released their 24th annual report Beyond borders: global biotechnology report 2010, presenting, among other things, five guiding principles for biotech companies working in the new economy where funding is scarce and customers careful:
    Seizing funding opportunities. Companies need to broaden the search for capital to include nontraditional (and non-dilutive) sourc

  • Attana- inspiring health

    At Attana we aim at improving health in society by helping our customers in their scientific research, whether they are university researchers or pharmaceutical companies developing efficient treatment against severe diseases. However, another way to stay healthy is to eat wisely and exercise, and we Attanians exercise in abundance. For instance, several years in a row Attana has...

  • Universities and Innovation

    We consider it strategically important to keep collaborating with our customers, university researchers in particular, to stay on top and keep getting inspired.

Relaterade event